These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 22297833)

  • 1. Metastatic mammary carcinoma with DCIS-like morphology: a report of two cases.
    Coyne J
    Int J Surg Pathol; 2012 Oct; 20(5):485-7. PubMed ID: 22297833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ductal carcinoma in situ-like structures in metastatic breast carcinoma.
    Kordek R
    Pathol Res Pract; 2005; 200(11-12):831-4. PubMed ID: 15792128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunocytochemical localization of secreted transforming growth factor-beta 1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma.
    Dalal BI; Keown PA; Greenberg AH
    Am J Pathol; 1993 Aug; 143(2):381-9. PubMed ID: 8393616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor size as predictor of microinvasion, invasion, and axillary metastasis in ductal carcinoma in situ.
    Maffuz A; Barroso-Bravo S; Nájera I; Zarco G; Alvarado-Cabrero I; Rodríguez-Cuevas SA
    J Exp Clin Cancer Res; 2006 Jun; 25(2):223-7. PubMed ID: 16918134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costimulatory molecule OX40/OX40L expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
    Xie F; Wang Q; Chen Y; Gu Y; Mao H; Zeng W; Zhang X
    Pathol Res Pract; 2010 Nov; 206(11):735-9. PubMed ID: 20634005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial displacement into the lymphovascular space can be seen in breast core needle biopsy specimens.
    Koo JS; Jung WH; Kim H
    Am J Clin Pathol; 2010 May; 133(5):781-7. PubMed ID: 20395526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Con: Sentinel lymph node biopsy for DCIS. The breast surgeon is not a barber.
    Kuerer HM
    Ann Surg Oncol; 2007 Mar; 14(3):1007-8. PubMed ID: 17009142
    [No Abstract]   [Full Text] [Related]  

  • 8. Pro: SLNB in DCIS.
    Fuhrman GM
    Ann Surg Oncol; 2007 Mar; 14(3):1005-6. PubMed ID: 17180481
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lymph node metastasis of a "squamous cell carcinoma" as a manifestation of occult breast cancer].
    Ronay G; Zimmermann HD; Tulusan AH
    Pathologe; 1988 Sep; 9(5):309-12. PubMed ID: 2845387
    [No Abstract]   [Full Text] [Related]  

  • 10. Factors associated with lymph node assessment in ductal carcinoma in situ: analysis of 1988-2002 seer data.
    Porembka MR; Abraham RL; Sefko JA; Deshpande AD; Jeffe DB; Margenthaler JA
    Ann Surg Oncol; 2008 Oct; 15(10):2709-19. PubMed ID: 18483831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and biological characteristics of breast cancer.
    Kocic B; Filipovic S; Petrovic B; Mijalkovic D; Rancic N; Poultsidi A
    J BUON; 2010; 15(4):660-7. PubMed ID: 21229626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HE4 expression can be associated with lymph node metastases and disease-free survival in breast cancer.
    Kamei M; Yamashita S; Tokuishi K; Hashioto T; Moroga T; Suehiro S; Ono K; Miyawaki M; Takeno S; Yamamoto S; Kawahara K
    Anticancer Res; 2010 Nov; 30(11):4779-83. PubMed ID: 21115941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour-positive sentinel node findings in patients with ductal carcinoma in situ.
    Leidenius M; Salmenkivi K; von Smitten K; Heikkilä P
    J Surg Oncol; 2006 Oct; 94(5):380-4. PubMed ID: 16967467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarcomatoid breast tumors have sarcomatoid behavior.
    Gilcrease MZ
    Am J Surg Pathol; 2007 Feb; 31(2):326-7; author reply 327. PubMed ID: 17255781
    [No Abstract]   [Full Text] [Related]  

  • 15. Breast carcinoma with chondroid differentiation: a clinicopathologic study of 21 triple negative (ER-, PR-, Her2/neu-) cases.
    Gwin K; Wheeler DT; Bossuyt V; Tavassoli FA
    Int J Surg Pathol; 2010 Feb; 18(1):27-35. PubMed ID: 19282292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of invasion and axillary lymph node metastasis in patients with a core biopsy diagnosis of ductal carcinoma in situ: an analysis of 255 cases.
    Han JS; Molberg KH; Sarode V
    Breast J; 2011; 17(3):223-9. PubMed ID: 21545433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ductal carcinoma in situ: value of sentinel lymph node biopsy.
    Sakr R; Barranger E; Antoine M; Prugnolle H; Daraï E; Uzan S
    J Surg Oncol; 2006 Oct; 94(5):426-30. PubMed ID: 16967457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and clinical significance of lymph node metastasis detected by cytokeratin immunohistochemical staining in ductal carcinoma in situ.
    El-Tamer M; Chun J; Gill M; Bassi D; Lee S; Hibshoosh H; Mansukhani M
    Ann Surg Oncol; 2005 Mar; 12(3):254-9. PubMed ID: 15827818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the S classification of sentinel lymph node and microanatomic location of sentinel lymph node metastases to predict additional lymph node involvement and overall survival in breast cancer patients.
    Fink AM; Wondratsch H; Lass H; Janauer M; Sevelda P; Salzer H; Jurecka W; Ulrich W; Chott A; Steiner A
    Ann Surg Oncol; 2011 Jun; 18(6):1691-7. PubMed ID: 21249455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant expression of epithelial-mesenchymal transition biomarkers in breast ductal carcinoma: association with progression.
    Logullo AF; Nonogaki S; Pasini FS; Osório CA; Soares FA; Brentani MM
    Oncol Rep; 2010 Feb; 23(2):313-20. PubMed ID: 20043090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.